IGF2BP2 is markedly overexpressed in AML and modulates crucial genes such as MYC, GPT2, and SLC1A5 through a m6A-dependent mechanism, thereby playing a pivotal role in glutamine metabolism and contributing to the pathogenesis and progression of AML (137). Here, MYC is linked to acute myeloid leukemia.